Guest guest Posted April 25, 2012 Report Share Posted April 25, 2012 I always use the rule of thumb if it is diagnostic and it is required to determine if they can have the transplant, then it is cost reportable. Treatment is not. Deidra M. Simano Transplant Operations Analyst Department of Transplant Surgery Dartmouth-Hitchcock Lebanon Phone: (603) 653.3689 / Fax: (603) 676.4287 Transplant Secretary (603) 653.3931 Dartmouth-Hitchcock.org From: TxFinancialCoordinators [mailto:TxFinancialCoordinators ] On Behalf Of Danner, Sara Sent: Wednesday, April 25, 2012 3:56 PM To: TxFinancialCoordinators Subject: Hep C for a kidney patient If a pre-transplant kidney patient has Hep C, and we ask for a liver biopsy….is that still considered eval that can be billed to KACC? What if Hep C treatment is needed after biopsy? Is that to be billed to insurance? Sara Danner | Transplant Financial Coordinator | Memorial Medical Center | Springfield, IL Phone: | Fax: | E-mail: danner.sara@... CHOOSE GREAT. CHOOSE MEMORIAL. This message (including any attachments) contains confidential information intended for a specific individual and purpose, and is protected by law. If you are not the intended recipient, you should delete this message. Any disclosure, copying, or distribution of this message, or the taking of any action based on it, is strictly prohibited. IMPORTANT NOTICE REGARDING THIS ELECTRONIC MESSAGE: This message is intended for the use of the person to whom it is addressed and may contain information that is privileged, confidential, and protected from disclosure under applicable law. If you are not the intended recipient, your use of this message for any purpose is strictly prohibited. If you have received this communication in error, please delete the message and notify the sender so that we may correct our records. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted April 25, 2012 Report Share Posted April 25, 2012 So, if a living donor had an EKG and they found something that they wanted to check into further and a stress ECHO was ordered, would you put both the EKG and the ECHO to the KACC, just the EKG to the KACC and ECHO to patient’s insurance, or both to patient’s insurance? M. Christiansen, BAS, RNTransplant Financial Case Manager DeVos Heart and Lung Transplant Program100 Michigan NEMC 231Grand Rapids, MI 49503Phone: Pager: Fax: lisa.christiansen@... From: TxFinancialCoordinators [mailto:TxFinancialCoordinators ] On Behalf Of Deidra M. SimanoSent: Wednesday, April 25, 2012 3:58 PMTo: txfinancialcoordinators Subject: RE: Hep C for a kidney patient I always use the rule of thumb if it is diagnostic and it is required to determine if they can have the transplant, then it is cost reportable. Treatment is not. Deidra M. SimanoTransplant Operations AnalystDepartment of Transplant SurgeryDartmouth-Hitchcock LebanonPhone: (603) 653.3689 / Fax: (603) 676.4287Transplant Secretary (603) 653.3931Dartmouth-Hitchcock.org From: TxFinancialCoordinators [mailto:TxFinancialCoordinators ] On Behalf Of Danner, SaraSent: Wednesday, April 25, 2012 3:56 PMTo: TxFinancialCoordinators Subject: Hep C for a kidney patient If a pre-transplant kidney patient has Hep C, and we ask for a liver biopsy….is that still considered eval that can be billed to KACC? What if Hep C treatment is needed after biopsy? Is that to be billed to insurance? Sara Danner | Transplant Financial Coordinator | Memorial Medical Center | Springfield, ILPhone: | Fax: | E-mail: danner.sara@... CHOOSE GREAT. CHOOSE MEMORIAL. This message (including any attachments) contains confidential information intended for a specific individual and purpose, and is protected by law. If you are not the intended recipient, you should delete this message. Any disclosure, copying, or distribution of this message, or the taking of any action based on it, is strictly prohibited.IMPORTANT NOTICE REGARDING THIS ELECTRONIC MESSAGE:This message is intended for the use of the person to whom it is addressed and may contain information that is privileged, confidential, and protected from disclosure under applicable law. If you are not the intended recipient, your use of this message for any purpose is strictly prohibited. If you have received this communication in error, please delete the message and notify the sender so that we may correct our records. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted April 25, 2012 Report Share Posted April 25, 2012 Both go to the cost report. They are not treatment but eval. Ruth Wilhelm Financial Coordinator The Virginia Transplant Center Henrico Doctors' Hospital Henrico, VA phone fax Ruth.Wilhelm@... Treasurer, Transplant Financial Coordinators Association From: TxFinancialCoordinators [mailto:TxFinancialCoordinators ] On Behalf Of lisa.christiansen@...Sent: Wednesday, April 25, 2012 4:01 PMTo: txfinancialcoordinators Subject: RE: Hep C for a kidney patient So, if a living donor had an EKG and they found something that they wanted to check into further and a stress ECHO was ordered, would you put both the EKG and the ECHO to the KACC, just the EKG to the KACC and ECHO to patient’s insurance, or both to patient’s insurance? M. Christiansen, BAS, RNTransplant Financial Case Manager DeVos Heart and Lung Transplant Program100 Michigan NEMC 231Grand Rapids, MI 49503Phone: Pager: Fax: lisa.christiansen@... From: TxFinancialCoordinators [mailto:TxFinancialCoordinators ] On Behalf Of Deidra M. SimanoSent: Wednesday, April 25, 2012 3:58 PMTo: txfinancialcoordinators Subject: RE: Hep C for a kidney patient I always use the rule of thumb if it is diagnostic and it is required to determine if they can have the transplant, then it is cost reportable. Treatment is not. Deidra M. SimanoTransplant Operations AnalystDepartment of Transplant SurgeryDartmouth-Hitchcock LebanonPhone: (603) 653.3689 / Fax: (603) 676.4287Transplant Secretary (603) 653.3931Dartmouth-Hitchcock.org From: TxFinancialCoordinators [mailto:TxFinancialCoordinators ] On Behalf Of Danner, SaraSent: Wednesday, April 25, 2012 3:56 PMTo: TxFinancialCoordinators Subject: Hep C for a kidney patient If a pre-transplant kidney patient has Hep C, and we ask for a liver biopsy….is that still considered eval that can be billed to KACC? What if Hep C treatment is needed after biopsy? Is that to be billed to insurance? Sara Danner | Transplant Financial Coordinator | Memorial Medical Center | Springfield, ILPhone: | Fax: | E-mail: danner.sara@... CHOOSE GREAT. CHOOSE MEMORIAL. This message (including any attachments) contains confidential information intended for a specific individual and purpose, and is protected by law. If you are not the intended recipient, you should delete this message. Any disclosure, copying, or distribution of this message, or the taking of any action based on it, is strictly prohibited.IMPORTANT NOTICE REGARDING THIS ELECTRONIC MESSAGE:This message is intended for the use of the person to whom it is addressed and may contain information that is privileged, confidential, and protected from disclosure under applicable law. If you are not the intended recipient, your use of this message for any purpose is strictly prohibited. If you have received this communication in error, please delete the message and notify the sender so that we may correct our records. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted April 25, 2012 Report Share Posted April 25, 2012 Ruth,Thank you so much! This seems to always be very confusing to know where to allocate the charges. Is it just best to allocate them to the KACC if in doubt? M. Christiansen, BAS, RNTransplant Financial Case Manager DeVos Heart and Lung Transplant Program100 Michigan NEMC 231Grand Rapids, MI 49503Phone: Pager: Fax: lisa.christiansen@... From: TxFinancialCoordinators [mailto:TxFinancialCoordinators ] On Behalf Of Ruth.Wilhelm@...Sent: Wednesday, April 25, 2012 4:03 PMTo: TxFinancialCoordinators Subject: RE: Hep C for a kidney patient Both go to the cost report. They are not treatment but eval. Ruth Wilhelm Financial Coordinator The Virginia Transplant Center Henrico Doctors' Hospital Henrico, VA phone fax Ruth.Wilhelm@... Treasurer, Transplant Financial Coordinators Association From: TxFinancialCoordinators [mailto:TxFinancialCoordinators ] On Behalf Of lisa.christiansen@...Sent: Wednesday, April 25, 2012 4:01 PMTo: txfinancialcoordinators Subject: RE: Hep C for a kidney patient So, if a living donor had an EKG and they found something that they wanted to check into further and a stress ECHO was ordered, would you put both the EKG and the ECHO to the KACC, just the EKG to the KACC and ECHO to patient’s insurance, or both to patient’s insurance? M. Christiansen, BAS, RNTransplant Financial Case Manager DeVos Heart and Lung Transplant Program100 Michigan NEMC 231Grand Rapids, MI 49503Phone: Pager: Fax: lisa.christiansen@... From: TxFinancialCoordinators [mailto:TxFinancialCoordinators ] On Behalf Of Deidra M. SimanoSent: Wednesday, April 25, 2012 3:58 PMTo: txfinancialcoordinators Subject: RE: Hep C for a kidney patient I always use the rule of thumb if it is diagnostic and it is required to determine if they can have the transplant, then it is cost reportable. Treatment is not. Deidra M. SimanoTransplant Operations AnalystDepartment of Transplant SurgeryDartmouth-Hitchcock LebanonPhone: (603) 653.3689 / Fax: (603) 676.4287Transplant Secretary (603) 653.3931Dartmouth-Hitchcock.org From: TxFinancialCoordinators [mailto:TxFinancialCoordinators ] On Behalf Of Danner, SaraSent: Wednesday, April 25, 2012 3:56 PMTo: TxFinancialCoordinators Subject: Hep C for a kidney patient If a pre-transplant kidney patient has Hep C, and we ask for a liver biopsy….is that still considered eval that can be billed to KACC? What if Hep C treatment is needed after biopsy? Is that to be billed to insurance? Sara Danner | Transplant Financial Coordinator | Memorial Medical Center | Springfield, ILPhone: | Fax: | E-mail: danner.sara@... CHOOSE GREAT. CHOOSE MEMORIAL. This message (including any attachments) contains confidential information intended for a specific individual and purpose, and is protected by law. If you are not the intended recipient, you should delete this message. Any disclosure, copying, or distribution of this message, or the taking of any action based on it, is strictly prohibited.IMPORTANT NOTICE REGARDING THIS ELECTRONIC MESSAGE:This message is intended for the use of the person to whom it is addressed and may contain information that is privileged, confidential, and protected from disclosure under applicable law. If you are not the intended recipient, your use of this message for any purpose is strictly prohibited. If you have received this communication in error, please delete the message and notify the sender so that we may correct our records. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted April 25, 2012 Report Share Posted April 25, 2012 Oh, no! Eval: KACCTreatment: insurance.And when in doubt, just ask. We’ll all help. From: TxFinancialCoordinators [mailto:TxFinancialCoordinators ] On Behalf Of lisa.christiansen@...Sent: Wednesday, April 25, 2012 4:51 PMTo: txfinancialcoordinators Subject: RE: Hep C for a kidney patient Ruth,Thank you so much! This seems to always be very confusing to know where to allocate the charges. Is it just best to allocate them to the KACC if in doubt? M. Christiansen, BAS, RNTransplant Financial Case Manager DeVos Heart and Lung Transplant Program100 Michigan NEMC 231Grand Rapids, MI 49503Phone: Pager: Fax: lisa.christiansen@... From: TxFinancialCoordinators [mailto:TxFinancialCoordinators ] On Behalf Of Ruth.Wilhelm@...Sent: Wednesday, April 25, 2012 4:03 PMTo: TxFinancialCoordinators Subject: RE: Hep C for a kidney patient Both go to the cost report. They are not treatment but eval. Ruth Wilhelm Financial Coordinator The Virginia Transplant Center Henrico Doctors' Hospital Henrico, VA phone fax Ruth.Wilhelm@... Treasurer, Transplant Financial Coordinators Association From: TxFinancialCoordinators [mailto:TxFinancialCoordinators ] On Behalf Of lisa.christiansen@...Sent: Wednesday, April 25, 2012 4:01 PMTo: txfinancialcoordinators Subject: RE: Hep C for a kidney patient So, if a living donor had an EKG and they found something that they wanted to check into further and a stress ECHO was ordered, would you put both the EKG and the ECHO to the KACC, just the EKG to the KACC and ECHO to patient’s insurance, or both to patient’s insurance? M. Christiansen, BAS, RNTransplant Financial Case Manager DeVos Heart and Lung Transplant Program100 Michigan NEMC 231Grand Rapids, MI 49503Phone: Pager: Fax: lisa.christiansen@... From: TxFinancialCoordinators [mailto:TxFinancialCoordinators ] On Behalf Of Deidra M. SimanoSent: Wednesday, April 25, 2012 3:58 PMTo: txfinancialcoordinators Subject: RE: Hep C for a kidney patient I always use the rule of thumb if it is diagnostic and it is required to determine if they can have the transplant, then it is cost reportable. Treatment is not. Deidra M. SimanoTransplant Operations AnalystDepartment of Transplant SurgeryDartmouth-Hitchcock LebanonPhone: (603) 653.3689 / Fax: (603) 676.4287Transplant Secretary (603) 653.3931Dartmouth-Hitchcock.org From: TxFinancialCoordinators [mailto:TxFinancialCoordinators ] On Behalf Of Danner, SaraSent: Wednesday, April 25, 2012 3:56 PMTo: TxFinancialCoordinators Subject: Hep C for a kidney patient If a pre-transplant kidney patient has Hep C, and we ask for a liver biopsy….is that still considered eval that can be billed to KACC? What if Hep C treatment is needed after biopsy? Is that to be billed to insurance? Sara Danner | Transplant Financial Coordinator | Memorial Medical Center | Springfield, ILPhone: | Fax: | E-mail: danner.sara@... CHOOSE GREAT. CHOOSE MEMORIAL. This message (including any attachments) contains confidential information intended for a specific individual and purpose, and is protected by law. If you are not the intended recipient, you should delete this message. Any disclosure, copying, or distribution of this message, or the taking of any action based on it, is strictly prohibited.IMPORTANT NOTICE REGARDING THIS ELECTRONIC MESSAGE:This message is intended for the use of the person to whom it is addressed and may contain information that is privileged, confidential, and protected from disclosure under applicable law. If you are not the intended recipient, your use of this message for any purpose is strictly prohibited. If you have received this communication in error, please delete the message and notify the sender so that we may correct our records. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted April 25, 2012 Report Share Posted April 25, 2012 I’m sorry…I did not really make myself clear in my e-mail. I do understand if it is truly “treatment” related, it goes to insurance. There are just some circumstances where it is more difficult to know if it is truly treatment or eval. I will definitely continue to ask! J M. Christiansen, BAS, RNTransplant Financial Case Manager DeVos Heart and Lung Transplant Program100 Michigan NEMC 231Grand Rapids, MI 49503Phone: Pager: Fax: lisa.christiansen@... From: TxFinancialCoordinators [mailto:TxFinancialCoordinators ] On Behalf Of Ruth.Wilhelm@...Sent: Wednesday, April 25, 2012 4:59 PMTo: TxFinancialCoordinators Subject: RE: Hep C for a kidney patient Oh, no! Eval: KACCTreatment: insurance.And when in doubt, just ask. We’ll all help. From: TxFinancialCoordinators [mailto:TxFinancialCoordinators ] On Behalf Of lisa.christiansen@...Sent: Wednesday, April 25, 2012 4:51 PMTo: txfinancialcoordinators Subject: RE: Hep C for a kidney patient Ruth,Thank you so much! This seems to always be very confusing to know where to allocate the charges. Is it just best to allocate them to the KACC if in doubt? M. Christiansen, BAS, RNTransplant Financial Case Manager DeVos Heart and Lung Transplant Program100 Michigan NEMC 231Grand Rapids, MI 49503Phone: Pager: Fax: lisa.christiansen@... From: TxFinancialCoordinators [mailto:TxFinancialCoordinators ] On Behalf Of Ruth.Wilhelm@...Sent: Wednesday, April 25, 2012 4:03 PMTo: TxFinancialCoordinators Subject: RE: Hep C for a kidney patient Both go to the cost report. They are not treatment but eval. Ruth Wilhelm Financial Coordinator The Virginia Transplant Center Henrico Doctors' Hospital Henrico, VA phone fax Ruth.Wilhelm@... Treasurer, Transplant Financial Coordinators Association From: TxFinancialCoordinators [mailto:TxFinancialCoordinators ] On Behalf Of lisa.christiansen@...Sent: Wednesday, April 25, 2012 4:01 PMTo: txfinancialcoordinators Subject: RE: Hep C for a kidney patient So, if a living donor had an EKG and they found something that they wanted to check into further and a stress ECHO was ordered, would you put both the EKG and the ECHO to the KACC, just the EKG to the KACC and ECHO to patient’s insurance, or both to patient’s insurance? M. Christiansen, BAS, RNTransplant Financial Case Manager DeVos Heart and Lung Transplant Program100 Michigan NEMC 231Grand Rapids, MI 49503Phone: Pager: Fax: lisa.christiansen@... From: TxFinancialCoordinators [mailto:TxFinancialCoordinators ] On Behalf Of Deidra M. SimanoSent: Wednesday, April 25, 2012 3:58 PMTo: txfinancialcoordinators Subject: RE: Hep C for a kidney patient I always use the rule of thumb if it is diagnostic and it is required to determine if they can have the transplant, then it is cost reportable. Treatment is not. Deidra M. SimanoTransplant Operations AnalystDepartment of Transplant SurgeryDartmouth-Hitchcock LebanonPhone: (603) 653.3689 / Fax: (603) 676.4287Transplant Secretary (603) 653.3931Dartmouth-Hitchcock.org From: TxFinancialCoordinators [mailto:TxFinancialCoordinators ] On Behalf Of Danner, SaraSent: Wednesday, April 25, 2012 3:56 PMTo: TxFinancialCoordinators Subject: Hep C for a kidney patient If a pre-transplant kidney patient has Hep C, and we ask for a liver biopsy….is that still considered eval that can be billed to KACC? What if Hep C treatment is needed after biopsy? Is that to be billed to insurance? Sara Danner | Transplant Financial Coordinator | Memorial Medical Center | Springfield, ILPhone: | Fax: | E-mail: danner.sara@... CHOOSE GREAT. CHOOSE MEMORIAL. This message (including any attachments) contains confidential information intended for a specific individual and purpose, and is protected by law. If you are not the intended recipient, you should delete this message. Any disclosure, copying, or distribution of this message, or the taking of any action based on it, is strictly prohibited.IMPORTANT NOTICE REGARDING THIS ELECTRONIC MESSAGE:This message is intended for the use of the person to whom it is addressed and may contain information that is privileged, confidential, and protected from disclosure under applicable law. If you are not the intended recipient, your use of this message for any purpose is strictly prohibited. If you have received this communication in error, please delete the message and notify the sender so that we may correct our records. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted April 25, 2012 Report Share Posted April 25, 2012 I understand. We’ve all been there at one time or another! From: TxFinancialCoordinators [mailto:TxFinancialCoordinators ] On Behalf Of lisa.christiansen@...Sent: Wednesday, April 25, 2012 5:03 PMTo: txfinancialcoordinators Subject: RE: Hep C for a kidney patient I’m sorry…I did not really make myself clear in my e-mail. I do understand if it is truly “treatment” related, it goes to insurance. There are just some circumstances where it is more difficult to know if it is truly treatment or eval. I will definitely continue to ask! J M. Christiansen, BAS, RNTransplant Financial Case Manager DeVos Heart and Lung Transplant Program100 Michigan NEMC 231Grand Rapids, MI 49503Phone: Pager: Fax: lisa.christiansen@... From: TxFinancialCoordinators [mailto:TxFinancialCoordinators ] On Behalf Of Ruth.Wilhelm@...Sent: Wednesday, April 25, 2012 4:59 PMTo: TxFinancialCoordinators Subject: RE: Hep C for a kidney patient Oh, no! Eval: KACCTreatment: insurance.And when in doubt, just ask. We’ll all help. From: TxFinancialCoordinators [mailto:TxFinancialCoordinators ] On Behalf Of lisa.christiansen@...Sent: Wednesday, April 25, 2012 4:51 PMTo: txfinancialcoordinators Subject: RE: Hep C for a kidney patient Ruth,Thank you so much! This seems to always be very confusing to know where to allocate the charges. Is it just best to allocate them to the KACC if in doubt? M. Christiansen, BAS, RNTransplant Financial Case Manager DeVos Heart and Lung Transplant Program100 Michigan NEMC 231Grand Rapids, MI 49503Phone: Pager: Fax: lisa.christiansen@... From: TxFinancialCoordinators [mailto:TxFinancialCoordinators ] On Behalf Of Ruth.Wilhelm@...Sent: Wednesday, April 25, 2012 4:03 PMTo: TxFinancialCoordinators Subject: RE: Hep C for a kidney patient Both go to the cost report. They are not treatment but eval. Ruth Wilhelm Financial Coordinator The Virginia Transplant Center Henrico Doctors' Hospital Henrico, VA phone fax Ruth.Wilhelm@... Treasurer, Transplant Financial Coordinators Association From: TxFinancialCoordinators [mailto:TxFinancialCoordinators ] On Behalf Of lisa.christiansen@...Sent: Wednesday, April 25, 2012 4:01 PMTo: txfinancialcoordinators Subject: RE: Hep C for a kidney patient So, if a living donor had an EKG and they found something that they wanted to check into further and a stress ECHO was ordered, would you put both the EKG and the ECHO to the KACC, just the EKG to the KACC and ECHO to patient’s insurance, or both to patient’s insurance? M. Christiansen, BAS, RNTransplant Financial Case Manager DeVos Heart and Lung Transplant Program100 Michigan NEMC 231Grand Rapids, MI 49503Phone: Pager: Fax: lisa.christiansen@... From: TxFinancialCoordinators [mailto:TxFinancialCoordinators ] On Behalf Of Deidra M. SimanoSent: Wednesday, April 25, 2012 3:58 PMTo: txfinancialcoordinators Subject: RE: Hep C for a kidney patient I always use the rule of thumb if it is diagnostic and it is required to determine if they can have the transplant, then it is cost reportable. Treatment is not. Deidra M. SimanoTransplant Operations AnalystDepartment of Transplant SurgeryDartmouth-Hitchcock LebanonPhone: (603) 653.3689 / Fax: (603) 676.4287Transplant Secretary (603) 653.3931Dartmouth-Hitchcock.org From: TxFinancialCoordinators [mailto:TxFinancialCoordinators ] On Behalf Of Danner, SaraSent: Wednesday, April 25, 2012 3:56 PMTo: TxFinancialCoordinators Subject: Hep C for a kidney patient If a pre-transplant kidney patient has Hep C, and we ask for a liver biopsy….is that still considered eval that can be billed to KACC? What if Hep C treatment is needed after biopsy? Is that to be billed to insurance? Sara Danner | Transplant Financial Coordinator | Memorial Medical Center | Springfield, ILPhone: | Fax: | E-mail: danner.sara@... CHOOSE GREAT. CHOOSE MEMORIAL. This message (including any attachments) contains confidential information intended for a specific individual and purpose, and is protected by law. If you are not the intended recipient, you should delete this message. Any disclosure, copying, or distribution of this message, or the taking of any action based on it, is strictly prohibited.IMPORTANT NOTICE REGARDING THIS ELECTRONIC MESSAGE:This message is intended for the use of the person to whom it is addressed and may contain information that is privileged, confidential, and protected from disclosure under applicable law. If you are not the intended recipient, your use of this message for any purpose is strictly prohibited. If you have received this communication in error, please delete the message and notify the sender so that we may correct our records. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.